Graduate School of Medical Sciences
A partnership with the Sloan Kettering Institute

News

Weill Cornell Medicine has received a $5.2 million, initial two-year award  from the Advanced Research Projects Agency for Health (ARPA-H) Lymphatic Imaging, Genomics, and pHenotyping Technologies (LIGHT) program to develop a comprehensive and innovative approach to diagnosing lymphatic disease. LIGHT is led by ARPA-H Program Manager Kimberley Steele, M.D., Ph.D.

The lymphatic system is a network of vessels, nodes and organs that drains excess fluid from tissues, filtering out waste...

Read More

Approximately 88% of adults view opioid overdose deaths as a very serious problem with high agreement across political groups, according to a national survey conducted by Weill Cornell Medicine researchers. However, political differences over who is responsible will shape the country’s next phase of drug policy.

Historically, Americans have viewed people who use opioids as primarily responsible for the overdose crisis, with conservatives especially emphasizing...

Read More

A new single-cell profiling technique has mapped pre-malignant gene mutations and their effects in solid tissues for the first time, in a study led by investigators at Weill Cornell Medicine and the New York Genome Center.

The research, published Dec. 31 in Cancer Discovery, demonstrates a practical method for simultaneously measuring specific DNA mutations and gene activity in thousands of individual cells from human tissue. The technique is expected to be useful for studying pre-...

Read More

Pain-sensing neurons in the gut kindle inflammatory immune responses that cause allergies and asthma, according to a new study by Weill Cornell Medicine. The findings, published Jan. 7 in Nature, suggest that current drugs may not be as effective because they only address the immune component of these conditions, overlooking the contribution of neurons.

“Today’s blockbuster biologics are sometimes only 50% effective and when the treatments do work, they sometimes lose their efficacy...

Read More

Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During their preparation for this battle, B cells transiently revert to a more flexible, or plastic, stem-cell-like state in the lymph nodes, according to a new preclinical study from Weill Cornell Medicine investigators. The results could help explain how many lymphomas develop from mature B cells rather than from stem cells, as many other cancers do, and guide researchers in...

Read More

Video of Folate deficiency: How it can rewrite your genes and fuel cancer Genetic alterations lie at the heart of cancer development, but scientists may have been overlooking a powerful driver of these changes—the everyday nutrients that feed our cells. “Most efforts have focused on known carcinogens—like tobacco smoke or radiation,” said Dr. John Blenis, the Anna-Maria and Stephen Kellen Professor in Cancer Research in pharmacology at Weill Cornell Medicine. “But metabolism has been...

Read More

Gut microbes may play a key role in training a mother’s immune system to adapt to the developing fetus during pregnancy, according to a preclinical study by Weill Cornell Medicine investigators.

The findings, published Dec. 17 in Cell, show that beneficial gut bacteria help prevent immune system reactions that can lead to pregnancy loss in mice. The investigators demonstrated that metabolites produced by gut microbes promote the recruitment of two types of protective immune cells,...

Read More

Three minutes and one slide were all it took for twelve young scientists to turn cutting-edge research into dramatic stories of hope at Weill Cornell Medicine’s tenth annual Three-Minute Thesis (3MT) competition on Nov. 13 in Uris Auditorium. The night showcased bold ideas about tackling Alzheimer’s disease, cancer, infectious diseases and more with creativity and passion.

Students from Weill Cornell Graduate School of Medical Sciences, Gerstner Sloan Kettering Graduate School of...

Read More

Why are innovation and entrepreneurship important in academic research? Since the Bayh-Dole Act was passed in 1980, permitting institutions to retain ownership of their inventions arising from federal funding, more than 200 drug treatments and vaccines have been brought to market through academic-commercial partnerships.

Weill Cornell Medicine’s Ninth Annual Dean’s Symposium on Innovation and Entrepreneurship celebrated and fostered this entrepreneurial spirit on Nov. 17 at Weill...

Read More

Dopamine neurons in a part of the brain called the midbrain may, with aging, be increasingly susceptible to a vicious spiral of decline driven by fuel shortages, according to a study led by Weill Cornell Medicine investigators. The findings offer a potential explanation for the degeneration of this neuron population in Parkinson’s disease.

In the study, published Dec. 5 in the Proceedings of the National Academy of Sciences, the scientists examined how midbrain dopamine neurons, which...

Read More

Weill Cornell Medicine Graduate School of Medical Sciences 1300 York Ave. Box 65 New York, NY 10065 Phone: (212) 746-6565 Fax: (212) 746-8906